Global Pharmaceuticals & Biotech Most Popular Stocks

Welgene BiotechLtd

Market Cap: NT$520.8m

Provides genetic testing services.

Devonian Health Group

Market Cap: CA$23.8m

Engages in the development of botanical drugs.

PeterLabs Holdings Berhad

Market Cap: RM 71.6m

An investment holding company, engages in manufacturing, distribution, trading, and export of animal health and nutrition products for the livestock industry in Malaysia and internationally.

Active Fine Chemicals

Market Cap: ৳2.1b

Produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh.

Femtobiomed

Market Cap: ₩23.6b

Engages in the development of cargo-free intracellular delivery platform.

BCAL Diagnostics

Market Cap: AU$25.6m

A screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.

Longeveron

Market Cap: US$16.7m

A clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States.

Ainos

Market Cap: US$16.7m

A dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics.

Aytu BioPharma

Market Cap: US$16.7m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

Dong Sung Bio Pharm.Co.Ltd

Market Cap: ₩23.2b

Manufactures and sells pharmaceuticals and cosmetics in South Korea.

Institute of Biomedical Research

Market Cap: US$16.6m

Provides biomedical research and analytical services in Montenegro and internationally.

Bionano Genomics

Market Cap: US$16.6m

Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Smruthi Organics

Market Cap: ₹1.5b

Manufactures and markets active pharmaceutical ingredient (API) products to India.

Light AI

Market Cap: CA$22.9m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

Clal Biotechnology Industries

Market Cap: ₪55.1m

A private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.

Cocrystal Pharma

Market Cap: US$16.3m

A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.

Parnax Lab

Market Cap: ₹1.4b

Engages in the manufacture and export of pharmaceutical formulations in India and internationally.

GeoVax Labs

Market Cap: US$16.2m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Auro Laboratories

Market Cap: ₹1.4b

Manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India.

Rapid Dose Therapeutics

Market Cap: CA$22.6m

A life sciences company, provides drug delivery technologies in Canada.

Celyad Oncology

Market Cap: €13.8m

A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.

Biogened

Market Cap: zł59.0m

Develops, produces, and distributes pharmaceutical products in Poland.

Phapros

Market Cap: Rp268.8b

Operates in the pharmaceutical industry in Indonesia.

Ambee Pharmaceuticals

Market Cap: ৳2.0b

Engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh.

Pulmatrix

Market Cap: US$16.1m

A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

Tharimmune

Market Cap: US$16.0m

A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.

BioLineRx

Market Cap: ₪53.7m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Biosino Bio-Technology and Science Incorporation

Market Cap: HK$124.4m

Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.

Ananda Pharma

Market Cap: UK£11.8m

Operates as a biopharmaceutical company that develops cannabidiol-based medicine to treat chronic conditions in the United Kingdom and internationally.

Sabaa International Company for Pharmaceutical and Chemical Industry

Market Cap: ج.م762.5m

Engages in the manufacture and sale of generic medicines in Egypt.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Tyche Industries

Market Cap: ₹1.4b

Manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally.

iBio

Market Cap: US$15.7m

A preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space.

Philadelphia Pharmaceuticals

Market Cap: د.أ11.1m

Develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.

DuoGenic StemCells

Market Cap: NT$473.6m

Provides cell therapy products and stem cell culture related services.

Median Diagnostics

Market Cap: ₩21.8b

Develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals and human.